Loading, please wait ...


News Analytics

.
The IN VIVO Blog Publish date unknown
Prosensa is the worst-performing 2013 IPO, down 72%.GSK also has an anti-inflammatory and HCV deal with microRNAi company Regulus Therapeutics, initiated in 2008 and expanded in 2010; an anti-cancer stem cell antibody deal with OncoMed Pharmaceuticals that was for four candidate originally from 2007, but was cut down to two candidates in 2011; and a discovery deal with Five Prime Therapeutics for skeletal muscle diseases ...
Google

Subject Matter

  • Business, economics, society 36.51%
    • Companies, industries, organizations 100.00%
  • Science and technology 33.33%
  • Healthcare 30.16%
    • Hospitals, doctors and medical care 100.00%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions